The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19

Part of paid clinical trials in Everett, Washington.

Sponsor
N5 Sensors
Study ID
NCT06571136
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Study Details

The type and number of chemicals in exhaled breath are different in people with infection as compared to those without infection. In this study, the breath of people with and without COVID infection will be measured. Changes in the amount and type of chemicals in breath will be used to determine if an individual does or does not have COVID infection. If the measurements of breath are a reliable measure of COVID infection, this device may be used to rapidly screen people who are attending large public events (for example, music concert or baseball game) to minimize the spread of COVID at the event.

Key Dates

Start date
Aug 19, 2024
Status verified
Aug 2024
Primary completion
Feb 1, 2025
Completion
Feb 26, 2025

Study Design

Enrollment
60 participants (estimated)

Primary Outcome Measure

Exhaled chemicals in breath will be compared with COVID status [ Time Frame: On the day of enrollment, all measurement will be made over the course of 2 hours. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Providence Regional Medical Center EverettEverettWashington98201
Rebecca Watson, BS
[email protected]
425-261-3547
George Diaz, MD

Find similar trials in Everett, WA

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
Providence Regional Medical Center Everett· Everett, WA

Related Studies